Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-894 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 |
filingDate |
2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b6df0603972bf7669b3189c2fea091b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba15553aad483c6ad317fa3d88d4dbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85261ead98c70d802cd4bc9e353f369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d9a6cbbfc947abe3e69f5e5f48b510 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c53ef7cd7eb4720c996e5657102cea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a61e7e54c0fc543e5a454f07457f218 |
publicationDate |
2014-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8871812-B2 |
titleOfInvention |
Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis |
abstract |
The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. |
priorityDate |
2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |